SHAPING THE FUTURE OF IMMUNOTHERAPY
ABOUT US
THIS IS SHAPE
Shape Biopharmaceuticals is a next-generation immunotherapy developer. With our ambitious team and network, we strive to create a new class of immunotherapeutic drugs for chronic human diseases with high unmet treatment needs, leveraging cutting-edge computational epitope-specific antigen design and next-generation nanoparticle engineering technologies.
OUR FOCUS
WHAT WE DO
Optimizing Immunotherapy Design and Delivery
Antigen Engineering Technology
We employ leading-edge computational drug design and protein engineering technologies to optimize the immunological and antigenic properties of our target antigens.
Nano Formulation
We optimize the formulation using tailored nanoparticle-based delivery systems and specific immunomodulators to ensure optimal therapeutic responses in diverse patient populations.
ENABLING SMARTER IMMUNOTHERAPIES FOR PATIENTS
We are pioneering a new class of structurally defined, optimized, engineered nanomedicines that leverage the immune system to generate personalized therapeutic antibodies directly in patients.
To learn more about our current programs, please contact us here →
Registered Office in the U.S.:
- Shape Biopharmaceuticals Inc.
- 255 Main St, Cambridge, MA 02142
- info@shapebiopharma.com
Registered Office in Switzerland:
- Shape Biopharmaceuticals AG
- Riedhofstrasse 11, 8804 Au ZH, Switzerland
- info@shapebiopharma.com